Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate

L. F. Heinecke, M. W. Grzanna, A. Y. Au, C. A. Mochal, A. Rashmir-Raven, C. G. Frondoza

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the anti-inflammatory effect of the combination of avocado soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) on cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in cytokine-activated equine chondrocytes. Methods: Production of type II collagen and aggrecan was verified by immunohistochemistry and Western blot. Chondrocytes were incubated with: (1) control media alone, (2) ASU (4 μg/ml; 8.3 μg/ml), (3) EGCG (4, 40, 400 ng/ml), or (4) the combination of ASU and EGCG for 24 h. Cells were next incubated with control medium alone or with IL-1β (10 ng/ml) and TNF-α (1 ng/ml). COX-2 gene expression by real-time PCR analysis and NF-κB nuclear translocation by immunohistochemistry were performed after 1 h of incubation. PGE2 production was determined by immunoassay after 24 h of incubation. Results: Equine chondrocytes responded to cytokine activation by up-regulated gene expression of COX-2 and increased PGE2 production. Activation was associated with NF-κB translocation. Individually, ASU and EGCG marginally inhibited COX-2 expression and PGE2 production in activated chondrocytes. In contrast, the combination of ASU and EGCG reduced COX-2 expression close to non-activated control levels and significantly inhibited PGE2 production. These reductions were statistically greater than those of ASU or EGCG alone. The inhibition of COX-2 expression and PGE2 production was associated with inhibition of NF-κB translocation. Conclusion: The present study demonstrates that the anti-inflammatory activity of ASU and EGCG is potentiated when used in combination. This combination may offer an attractive supplement or alternative to non-steroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis.

Original languageEnglish (US)
Pages (from-to)220-227
Number of pages8
JournalOsteoarthritis and Cartilage
Volume18
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Persea
Cyclooxygenase 2
Chondrocytes
Soybeans
Dinoprostone
Anti-Inflammatory Agents
Gene expression
Horses
Chemical activation
Immunohistochemistry
Cytokines
Gene Expression
Aggrecans
Collagen Type II
Level control
epigallocatechin gallate
Prostaglandin-Endoperoxide Synthases
Interleukin-1
Immunoassay
Collagen

ASJC Scopus subject areas

  • Biomedical Engineering
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. / Heinecke, L. F.; Grzanna, M. W.; Au, A. Y.; Mochal, C. A.; Rashmir-Raven, A.; Frondoza, C. G.

In: Osteoarthritis and Cartilage, Vol. 18, No. 2, 02.2010, p. 220-227.

Research output: Contribution to journalArticle

Heinecke, L. F. ; Grzanna, M. W. ; Au, A. Y. ; Mochal, C. A. ; Rashmir-Raven, A. ; Frondoza, C. G. / Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. In: Osteoarthritis and Cartilage. 2010 ; Vol. 18, No. 2. pp. 220-227.
@article{aa576afbea614cdfbee8120ddbcc38d6,
title = "Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate",
abstract = "Objective: To evaluate the anti-inflammatory effect of the combination of avocado soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) on cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in cytokine-activated equine chondrocytes. Methods: Production of type II collagen and aggrecan was verified by immunohistochemistry and Western blot. Chondrocytes were incubated with: (1) control media alone, (2) ASU (4 μg/ml; 8.3 μg/ml), (3) EGCG (4, 40, 400 ng/ml), or (4) the combination of ASU and EGCG for 24 h. Cells were next incubated with control medium alone or with IL-1β (10 ng/ml) and TNF-α (1 ng/ml). COX-2 gene expression by real-time PCR analysis and NF-κB nuclear translocation by immunohistochemistry were performed after 1 h of incubation. PGE2 production was determined by immunoassay after 24 h of incubation. Results: Equine chondrocytes responded to cytokine activation by up-regulated gene expression of COX-2 and increased PGE2 production. Activation was associated with NF-κB translocation. Individually, ASU and EGCG marginally inhibited COX-2 expression and PGE2 production in activated chondrocytes. In contrast, the combination of ASU and EGCG reduced COX-2 expression close to non-activated control levels and significantly inhibited PGE2 production. These reductions were statistically greater than those of ASU or EGCG alone. The inhibition of COX-2 expression and PGE2 production was associated with inhibition of NF-κB translocation. Conclusion: The present study demonstrates that the anti-inflammatory activity of ASU and EGCG is potentiated when used in combination. This combination may offer an attractive supplement or alternative to non-steroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis.",
author = "Heinecke, {L. F.} and Grzanna, {M. W.} and Au, {A. Y.} and Mochal, {C. A.} and A. Rashmir-Raven and Frondoza, {C. G.}",
year = "2010",
month = "2",
doi = "10.1016/j.joca.2009.08.015",
language = "English (US)",
volume = "18",
pages = "220--227",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate

AU - Heinecke, L. F.

AU - Grzanna, M. W.

AU - Au, A. Y.

AU - Mochal, C. A.

AU - Rashmir-Raven, A.

AU - Frondoza, C. G.

PY - 2010/2

Y1 - 2010/2

N2 - Objective: To evaluate the anti-inflammatory effect of the combination of avocado soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) on cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in cytokine-activated equine chondrocytes. Methods: Production of type II collagen and aggrecan was verified by immunohistochemistry and Western blot. Chondrocytes were incubated with: (1) control media alone, (2) ASU (4 μg/ml; 8.3 μg/ml), (3) EGCG (4, 40, 400 ng/ml), or (4) the combination of ASU and EGCG for 24 h. Cells were next incubated with control medium alone or with IL-1β (10 ng/ml) and TNF-α (1 ng/ml). COX-2 gene expression by real-time PCR analysis and NF-κB nuclear translocation by immunohistochemistry were performed after 1 h of incubation. PGE2 production was determined by immunoassay after 24 h of incubation. Results: Equine chondrocytes responded to cytokine activation by up-regulated gene expression of COX-2 and increased PGE2 production. Activation was associated with NF-κB translocation. Individually, ASU and EGCG marginally inhibited COX-2 expression and PGE2 production in activated chondrocytes. In contrast, the combination of ASU and EGCG reduced COX-2 expression close to non-activated control levels and significantly inhibited PGE2 production. These reductions were statistically greater than those of ASU or EGCG alone. The inhibition of COX-2 expression and PGE2 production was associated with inhibition of NF-κB translocation. Conclusion: The present study demonstrates that the anti-inflammatory activity of ASU and EGCG is potentiated when used in combination. This combination may offer an attractive supplement or alternative to non-steroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis.

AB - Objective: To evaluate the anti-inflammatory effect of the combination of avocado soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) on cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in cytokine-activated equine chondrocytes. Methods: Production of type II collagen and aggrecan was verified by immunohistochemistry and Western blot. Chondrocytes were incubated with: (1) control media alone, (2) ASU (4 μg/ml; 8.3 μg/ml), (3) EGCG (4, 40, 400 ng/ml), or (4) the combination of ASU and EGCG for 24 h. Cells were next incubated with control medium alone or with IL-1β (10 ng/ml) and TNF-α (1 ng/ml). COX-2 gene expression by real-time PCR analysis and NF-κB nuclear translocation by immunohistochemistry were performed after 1 h of incubation. PGE2 production was determined by immunoassay after 24 h of incubation. Results: Equine chondrocytes responded to cytokine activation by up-regulated gene expression of COX-2 and increased PGE2 production. Activation was associated with NF-κB translocation. Individually, ASU and EGCG marginally inhibited COX-2 expression and PGE2 production in activated chondrocytes. In contrast, the combination of ASU and EGCG reduced COX-2 expression close to non-activated control levels and significantly inhibited PGE2 production. These reductions were statistically greater than those of ASU or EGCG alone. The inhibition of COX-2 expression and PGE2 production was associated with inhibition of NF-κB translocation. Conclusion: The present study demonstrates that the anti-inflammatory activity of ASU and EGCG is potentiated when used in combination. This combination may offer an attractive supplement or alternative to non-steroidal anti-inflammatory drugs (NSAIDs) in the management of osteoarthritis.

UR - http://www.scopus.com/inward/record.url?scp=74149084571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74149084571&partnerID=8YFLogxK

U2 - 10.1016/j.joca.2009.08.015

DO - 10.1016/j.joca.2009.08.015

M3 - Article

C2 - 19748608

AN - SCOPUS:74149084571

VL - 18

SP - 220

EP - 227

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 2

ER -